J PhagoMed advances phage therapy with eLabJournal Case StudyGoal Develop robust phage-based pharmaceuticals that are validated in rigorous clinical trials and immediately applied to the treatment of patients in need. PhagoMed Biopharma GmbH is an Austrian biotech company focused on the development of human therapeutic applications of phages and phage-derived proteins. Currently, PhagoMed has three active development programs in the fields of periprosthetic joint infections, urinary tract infections and bacterial vaginosis. These development programs are based on the experiences of its clinical co- founders with last-resort treatments, as well as research collaborations with highly prestigious scientists and research institutions in Germany and Belgium. Since its incorporatio

Join for free to read